| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75bfd3ad5e19bd23169036b207cce9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb5660d695d90496921ee76a4f592a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286dc5b582df48214edee33d8442e3ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ce8c62cc3c04ca81847e66e222d1ce |
| publicationDate |
2022-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022210783-A1 |
| titleOfInvention |
Follicular thyroid cancer-specific marker |
| abstract |
In order to differentiate follicular thyroid cancer (FTC) from follicular adenoma (FA), which has been problematic for conventional pathological diagnosis, a marker is provided in particular for which a clear cut-off value can be established.　Provided is a method and kit for diagnosing the occurrence of FTC in a subject, which are characterized by detection of the expression of FAM19A2 in a sample derived from the thyroid tissue of the subject. |
| priorityDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |